Breaking News

Averica Appoints Cynthia Berger VP of Operations

January 21, 2016

Previously worked as project manager at PCI Synthesis

Averica Discovery, an analytical development contract research organization (CRO) with specialized expertise in small molecule analysis and purification, has named Cynthia Berger vice president of operations.

In her new role, Dr. Berger will directly report to chief executive officer Jeff Kiplinger and is expected to contribute broadly to Averica's growth and development.

“We are excited to welcome Cindy, who will provide significant insight and guidance to our growth as an analytical development company,” said Dr. Kiplinger. “Cindy will be exploring new ways to expand our capabilities and enhance the value we bring to clients. She will also oversee the standardization of many of our processes as we move toward ISO 17025 certification and add GMP analytical capabilities. Her significant experience and strong understanding of the analytical services market, coupled with her strong operations, financial, and business background, make her an essential asset to the future of Averica.”

Prior to joining Averica Discovery, Dr. Berger served as project manager at PCI Synthesis, a contract manufacturing organization (CMO), where she managed multimillion dollar projects manufacturing active pharmaceutical ingredients. 
blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Why True CDMO Service Requires Flexibility, Responsiveness and Innovation

    James E. Gregory, UPM Pharmaceuticals||October 7, 2015
    Pharmaceutical and biopharmaceutical companies large and small are increasingly relying on third-party providers for support at all stages of drug development. To realize efficiencies, they are at the same time reducing the number of suppliers to a preferred few with whom they can form strategic partnerships.

  • CRO Outlook & Drug Development Trends

    CRO Outlook & Drug Development Trends

    Kristin Brooks , Contract Pharma||May 6, 2015
    CRO industry grows as increasingly complex R&D trends demand advanced expertise